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Evidence is presented which suggests that the (Y~HS glycoprotein &HS) receptor on lymphocytes 
transformed by Epstein-Barr virus (EBV) and the EBV-determined nuclear antigen (EBNA) are 
immunologically related, and may be identical. Western blotting, using both anti-EBNA and anti-cxzHS 
receptor serum identified a similar M, 48 000 component in labelled detergent-solubilized transformed cell 
supernatants. The M, 48 000 component recognized by anti-EBNA serum had a p1 between 7-8, similar 
to that reported for the cu2HS receptor. 
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1. INTRODUCTION 
The infection of B lymphocytes with Epstein- 
Barr virus (EBV) leads to cellular transformation 
and the expression of the EBV-determined nuclear 
antigen (EBNA) [l]. It is suspected that EBNA 
may play an essential role in the transformation 
process and maintenance of the transformed state 
[2]. Whether this suggested regulatory role of EB- 
NA is related to its ability to bind specific DNA se- 
quences is unknown [3]. Recently, EBNA has been 
shown to possess protein kinase activity [4], and 
this has strengthened the possibility that it may be 
a regulatory protein involved in the gene expres- 
sion of transformed cells. 
As EBNA is thought to play a role in the 
transformation process, it may also be of prime 
importance in immune defense mechanisms 
against infection by EBV and, as such, the interac- 
tion of EBNA with serum components may prove 
to be relevant. We have shown that the im- 
munomodulatory serum protein a42HS [5] binds to 
lymphocytes transformed by EBV, but not to nor- 
mal autologous non-transformed lymphocytes [a]. 
The a2HS receptor, like EBNA, has a monomeric 
MI 48 000 and the ability to bind DNA [7]. This 
suggests some relationship between the cr2HS 
receptor and EBNA. 
Here, we report evidence which implies that the 
crzHS receptor on lymphocytes transformed by 
EBV and EBNA may be identical. Antiserum rais- 
ed against the a2HS receptor immunoprecipitated 
the Mr 48 000 a2HS receptor, as shown by SDS- 
PAGE. The use of both this antiserum and anti- 
EBNA serum also resulted in localization of this 
M, 48 000 band from SDS-PAGE run in reducing 
conditions. Elution of the M, 48 000 band, iden- 
tified by anti-EBNA serum, from Western blots 
and subsequent isoelectric focusing resulted in a 
radioactive peak p1 7-8, similar to that of the 
a2HS receptor. Furthermore, we show by indirect 
immunofluorescence that anti-EBNA serum 
blocks the binding of crzHS to EBV-transformed 
lymphocytes. These results suggest that the cr2HS 
receptor and EBNA are immunologically related 
and may be identical. 
2. MATERIALS AND METHODS 
Peripheral blood lymphocytes were transformed 
with EBV culture supernatants derived from the 
B958 cell line [8], iodinated, and membranes 
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solubilized as in [7]. Indirect immunofluorescence 
was performed using a 1: 10 dilution of all antisera 
[7], and a2HS was isolated [9] and used at a final 
physiological concentration of 0.8 mg/ml. EBNA 
positive and EBNA negative human sera were used 
with titres against EBNA 80, viral capsid antigen 
(VCA) < 80, early antigen complex (EA) < 10; and 
EBNA ~2, VCA < 10, EA< 10, respectively. An- 
tiserum to the cr2HS receptor was raised in New 
Zealand white rabbits by subcutaneous injection. 
Four weeks after the initial injection of the isolated 
azHS receptor [7], a similar booster was given 
(10-20/g). Antiserum was harvested 10 days later. 
SDS-PAGE was carried out according to 
Laemmli [lo] in 5-20% gradient slab gels. 
Markers were phosphorylase B (Mr 97 000), bovine 
serum albumin (BSA, M, 68000), ovalbumin (Mr 
44 000), carbonix anhydrase (MI 29000), and 
lysozyme (Mr 14000): “‘1-cYi-antitrypsin (curAT) 
(Mr 54 000) was also used for autoradiography.io 
immuno-precipitation experiments 20 pl I- 
labelled detergent solubilized cell supernatant was 
incubated with 5 ~1 rabbit ant&HS receptor 
serum or 5 pl non-immune rabbit serum. Following 
incubation for 24 h at 4”C, 50~1 goat anti-rabbit 
serum (Wellcome) was added for a further 24 h at 
4°C. After centrifugation, the resulting precipitate 
was washed 5 x with PBS, incubated with 2% 
SDS containing mercaptoethanol(95’C for 5 min) 
and subjected to SDS-PAGE. Following elec- 
trophoresis gels were fixed in trichloroacetic acid, 
dried and autoradiographed. 
For Western blots, 100 ~1 aliquots of 1251- 
labelled detergent solubilized cell supernatants 
were subjected to SDS-PAGE and then transfer- 
red to nitrocellulose (Millipore HAWP, 45 pm) by 
overnight electrophoresis in 25 mM Tris, 192 mM 
glycine containing 20% methanol. The nitrocellu- 
lose was then blocked with 5% BSA in Tris-buf- 
fered saline (TBS, pH 7.4) containing 0.05% 
NP40, after which the nitrocellulose was incubated 
(60 min at 2O’C) in either EBNA positive, EBNA 
negative, rabbit anti_crzHS receptor or non- 
immune rabbit serum, all diluted 1:50 with TBS 
containing 5% BSA and 0.05% NP40. Following 
thrice washing in TBS containing 0.05% NP40, the 
nitrocellulose was incubated (60 min at 2O’C) in 
appropriate second antibody solution, either goat 
anti-human IgG-peroxidase labelled (1:3000, 
Tago) or goat anti-rabbit IgG-peroxidase labelled 
(1:3000, Tago) prepared in TBS containing 5% 
BSA and 0.05% NP40. After washing, the bands 
were visualised by incubation with 30 mg diamino- 
benzidine in 100 ml 0.1 M Tris-HCl @H 7.6) con- 
taining 40 pl Hz02 (30% solution). The enzyme 
reaction was terminated by washing in water. The 
nitrocellulose was dried, photographed and auto- 
radiographed, allowing exact identification of 
peroxidase-stained bands. 
The peroxidase-labelled Mr 48000 band, iden- 
tified with anti-EBNA serum from SDS-PAGE of 
a sample run in reducing conditions, was carefully 
cut from the nitrocellulose sheet, together with the 
non-peroxidase labelled region of similar mobility 
of a sample run in non-reducing conditions. Each 
region was solubilized with acid-acetone and the 
precipitate resuspended in 8 M urea for isoelectric 
focusing in 4% polyacrylamide disc gels containing 
8 M urea and 4% ampholine solution. After focus- 
ing, the gels were sliced into 2 mm segments and 
placed in tubes with 0.5 ml distilled water. Gel 
slices were counted and the pH of the eluted frac- 
tions determined. 
3. RESULTS 
The initial incubation of, viable EBV- 
transformed lymphocytes with anti-EBNA serum 
prior to sequential incubations with a2HS, rabbit 
anti_cuzHS serum and sheep anti-rabbit immuno- 
globulinfluorescein isothiocyanate (FITC), block- 
ed fluorescence, compared to cells initially in- 
cubated with cvzHS followed by rabbit anti_cuzHS 
serum and sheep anti-rabbit immunoglobulin- 
FITC, or cells incubated initially with anti-EBNA 
serum, followed by rabbit anti-human IgG and 
sheep anti-rabbit immunoglobulin-FITC. 
Immunoprecipitates produced by incubation of 
‘251-labelled detergent solubilized cell supernatants 
with rabbit anti_ruzHS serum revealed a single M, 
48 000 component compared to non-immune rab- 
bit serum (fig.1). This antiserum also revealed a 
major MI 48000 component from Western blots 
only when the labelled detergent solubilized cell 
supernatants were initially subjected to SDS- 
PAGE in reducing conditions (fig.2). Similarly, a 
M, 48 000 component was identified from Western 
blots using anti-EBNA serum only when the labell- 
ed detergent solubilized cell supernatants were in- 
itially run by SDS-PAGE under reducing condi- 
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Fig. 1. Autoradiograph of 1251-labelled proteins analyzed 
by SDS-PAGE. Labelled detergent solubilized EBV- 
transformed lymphocyte supernatants (20 ~1) with (a) 
and without (b) mercaptoethanol. Immunoprecipitates 
with rabbit anti_cuzHS receptor serum 1, rabbit anti- 
cvzHS receptor serum 2, and non-immune rabbit serum, 
c, d and e respectively. The A4, 48000 CY~HS receptor 
band is indicated. 
tions (fig.3). Minor components of M, 54000 and 
Mr 71000 were also identified. The use of EBNA- 
negative serum revealed no peroxidase staining 
bands. 
The isoelectric focusing profiles of the extracted 
peroxidase-labelled Mr 48 000 component iden- 
tified by EBNA-positive serum in a sample run in 
reducing conditions, and the equivalent region 
from a sample run in non-reducing conditions, are 
shown in fig.4. The presence of an additional com- 
ponent, ~17-8 in the reduced sample compared to 
Fig.2. Western blots and autoradiographs of 1251-labelled detergent-solubilized EBV-transformed lymphocyte super- 
natants (100 ,uI) after transfer to nitrocellulose. Lanes a, b and c are Western blots using rabbit anti_cuzHS receptor 
serum 1 of labelled detergent solubilized cell supernatants initially separated by SDS-PAGE in the absence (a) and 
presence (b) of mercaptoethanol. Lane c shows the ‘251-curAT marker (MI 54000). Lanes d-f are autoradrographs 
of lanes a-c, respectively. Lanes g and h are Western blots using non-immune rabbit serum of labelled detergent 
solubilized cell supematants initially separated by SDS-PAGE in the absence and presence of mercaptoethanol, respec- 
tively. Lanes i and j are autoradiographs of lanes g and h, respectively. The MI 48000 band is indicated. 
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Fig.3. Western blots and autoradiographs of lZSI-labelled detergent solubiliied EBV-transformed lymphocyte super- 
natants (100 /tl) after transfer to nitrocellulose. Lanes a and b are Western blots using anti-EBNA serum of labelled 
detergent solubilized cell supernatants initially separated by SDS-PAGE in the absence (a) and presence (b) of mercap- 
toethanol. Lanes c and d are autoradiographs of a and b, respectively. Lanes e and f are Western blots using EBNA- 
negative serum of labelled detergent solubilized cell supernatants initially separated by SDS-PAGE in the absence (e) 
and presence (f) of mercaptoethanol. Lanes g and h are autoradiographs of e and f, respectively. The M, 48000 band 
is indicated together with minor components M54000 and IU, 71000. 
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Fig.4. Isoelectric focusing of the eluted M, 48000 peroxidase-staining band from nitrocellulose identified by anti-EBNA 
serum of a labelled detergent solubilized cell supernatant run in the presence of mercaptoethanol (a). The corresponding 
non-peroxidase-staining region of similar mobility (Mr 48000) was eluted from nitrocellulose of a labelled detergent- 
solubilized cell supernatant run in the absence. of mercaptoethanol and also subjected to isoelectric focusing (b). After 
focusing, gels were sliced into 2 mm segments and counted. Radioactivity is expressed as cpm after background subtrac- 
tion. The pH gradient is also indicated (---) using ampholines (pH 3-10). 
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the non-reduced sample, suggests that it is this 
component which is responsible for the peroxidase 
labelling using anti-EBNA serum. This corres- 
ponds to the p1 of the crzHS receptor [7]. 
4. DISCUSSION 
Although rabbit anti_ruzHS receptor sera were 
capable of precipitating the cvzHS receptor from 
labelled detergent solubilized cell supernatants 
(fig.l), the use of anti-EBNA serum followed by 
rabbit anti-human IgG resulted in immunoprecipi- 
tation of all bands (not shown). 
Electrotransfer to nltrocellulose of the labelled 
detergent solubilized cell supernatants following 
SDS-PAGE resulted in a slight loss of transfer of 
higher-M, components (fig. 1-3). The resulting 
Western blots using either anti_cuzHS receptor or 
anti-EBNA serum showed the peroxidase-staining 
MI 48000 band only when samples were run in 
reducing conditions (fig.2,3). This suggests that 
both these antisera are recognizing the same com- 
ponent. This component could be derived from a 
higher-Mr species which is not identified under 
non-reducing conditions, due to incomplete elec- 
trotransfer of higher&, components. 
Isoelectric focusing confirms the suggestion that 
the anti-EBNA serum-identified M, 48 000 compo- 
nent is the cvzHS receptor. The (u~HS receptor, like 
EBNA, exists in an aggregated form, and like EB- 
NA, has a monomeric A4, 48 000 [7,11]. It 
therefore seems likely that the cvzHS receptor and 
EBNA are not only immunologically related but 
are identical. This is supported by the findings 
from indirect immunofluorescence, where anti- 
EBNA serum blocked the binding of a2HS. 
The anti-EBNA serum also recognized two 
minor components, MI 54000 and MI 71000 
(fig.3). Whether these correspond to multiple EB- 
NA forms is unknown. In non-producer cell lines, 
such as those derived from B95-8 supernatants, 
there is sufficient mRNA derived from EBV DNA 
to code for several medium size proteins [3]. 
Although the p1 of EBNA has been reported, some 
uncertainty exists, as it is claimed by some to be an 
acidic protein, and by others to share biochemical 
properties with the histones [3]. The nature of this 
variation, together with the variation in M, may 
reflect the existence of multiple EBNAs. Western 
blots using anti_cuzHS receptor serum showed 
310 
minor components of higher M, in both the label- 
led detergent solubilized cell supernatants and the 
1251+iAT marker (fig.2). Hence, these minor com- 
ponents are probably spurious, especially in view 
of the ability of this antibody to immuno- 
precipitate only the w 48000 from labelled 
detergent solubilized cell supernatants analyzed by 
SDS-PAGE (fig. 1). 
The results suggest that the azHS receptor on 
lymphocytes transformed by EBV and EBNA are 
immunologically related and may be identical. As 
EBNA seems to play an important regulatory role 
in EBV-transformed cells, the question as to 
whether azHS can directly alter transformation or 
proliferation of these EBV-transformed cells 
merits attention. In addition, the use of 
cYzHS-Sepharose 4B should prove useful for the 
isolation of EBNA for subsequent antiserum 
production. 
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